Predictors of gastrointestinal complaints in patients on metformin therapy

Although being very effective in the treatment of diabetes and a few other conditions, metformin (MTF) cannot be tolerated by many patients due to gastrointestinal (GI) complaints. A number of risk factors for intolerance were identified, but many are still controversial or uninvestigated. The aim o...

Full description

Bibliographic Details
Main Authors: Raičević Branislava, Janković Slobodan
Format: Article
Language:English
Published: De Gruyter 2023-11-01
Series:Open Medicine
Subjects:
Online Access:https://doi.org/10.1515/med-2023-0871
Description
Summary:Although being very effective in the treatment of diabetes and a few other conditions, metformin (MTF) cannot be tolerated by many patients due to gastrointestinal (GI) complaints. A number of risk factors for intolerance were identified, but many are still controversial or uninvestigated. The aim of this study was to further investigate possible risk factors for the occurrence of GI complaints in patients on MTF therapy. A cross-sectional design was used for this multicentric study on adult patients visiting 50 community pharmacies in Montenegro. The patients were surveyed by semi-structured questionnaire after a service of a pharmacist was delivered, and their drugs dispensed. Uni- and multi-variate regression methods were used for processing the data.
ISSN:2391-5463